These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25228365)

  • 81. Current status of research and treatment for non-small cell lung cancer in never-smoking females.
    Saito S; Espinoza-Mercado F; Liu H; Sata N; Cui X; Soukiasian HJ
    Cancer Biol Ther; 2017 Jun; 18(6):359-368. PubMed ID: 28494184
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients.
    Bichev SN; Marinova DM; Slavova YG; Savov AS
    Cell Oncol (Dordr); 2015 Apr; 38(2):145-53. PubMed ID: 25534657
    [TBL] [Abstract][Full Text] [Related]  

  • 83. ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.
    Reck M; Hagiwara K; Han B; Tjulandin S; Grohé C; Yokoi T; Morabito A; Novello S; Arriola E; Molinier O; McCormack R; Ratcliffe M; Normanno N
    J Thorac Oncol; 2016 Oct; 11(10):1682-9. PubMed ID: 27468938
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A comparative study of EGFR mutation screening methods in non-small cell carcinoma of lung.
    Gombos Z; Danihel L; Puttaswamy K; Brose M
    Bratisl Lek Listy; 2010; 111(7):365-8. PubMed ID: 20806539
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A rapid MZI-IDA sensor system for EGFR mutation testing in non-small cell lung cancer (NSCLC).
    Liu Q; Lim SY; Soo RA; Park MK; Shin Y
    Biosens Bioelectron; 2015 Dec; 74():865-71. PubMed ID: 26233643
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Comparison of two different methods for EGFR gene mutation detection in non-small cell lung cancer].
    Dong Z; Sun Y; Lu Y; Tang C; Xu Y; Liu Y; Zhu G; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):116-9. PubMed ID: 24742573
    [No Abstract]   [Full Text] [Related]  

  • 87. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis.
    Cheng Z; Shan F; Yang Y; Shi Y; Zhang Z
    BMC Med Imaging; 2017 Jan; 17(1):5. PubMed ID: 28068946
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma.
    da Cunha Santos G; Wyeth T; Reid A; Saieg MA; Pitcher B; Pintilie M; Kamel-Reid S; Tsao MS
    J Clin Pathol; 2016 Jul; 69(7):607-11. PubMed ID: 26733659
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Epidermal Growth Factor Receptor Tyrosine Kinase: A Potential Target in Treatment of Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj N
    J Environ Pathol Toxicol Oncol; 2017; 36(2):151-158. PubMed ID: 29199595
    [TBL] [Abstract][Full Text] [Related]  

  • 90. High incidence of EGFR mutations in pneumonic-type non-small cell lung cancer.
    Liu J; Shen J; Yang C; He P; Guan Y; Liang W; He J
    Medicine (Baltimore); 2015 Feb; 94(8):e540. PubMed ID: 25715252
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Complete remission of liver metastasis in a lung cancer patient with epidermal growth factor mutation achieved with Icotinib.
    Zhu Z; Chai Y
    Thorac Cancer; 2016 Nov; 7(6):681-683. PubMed ID: 27807951
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
    Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
    J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Incomplete uptake of EGFR mutation testing and its impact on estimation of mutation prevalence in patients with non-squamous NSCLC: A population-based study in New Zealand.
    Tin Tin S; McKeage MJ; Khwaounjoo P; Thi AM; Elwood JM
    Cancer Epidemiol; 2018 Dec; 57():24-32. PubMed ID: 30278336
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinicopathologic Features of Advanced Squamous NSCLC.
    Socinski MA; Obasaju C; Gandara D; Hirsch FR; Bonomi P; Bunn P; Kim ES; Langer CJ; Natale RB; Novello S; Paz-Ares L; Pérol M; Reck M; Ramalingam SS; Reynolds CH; Spigel DR; Stinchcombe TE; Wakelee H; Mayo C; Thatcher N
    J Thorac Oncol; 2016 Sep; 11(9):1411-22. PubMed ID: 27296106
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Targeted therapies for patients with advanced NSCLC harboring wild-type EGFR: what's new and what's enough.
    Zhou F; Zhou CC
    Chin J Cancer; 2015 Jul; 34(7):310-9. PubMed ID: 26187152
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Could molecular pathology testing in lung cancer be more cost-effective?
    Walsh K; Kheng YC; Oniscu A; Harrison DJ; Wallace WA
    J Clin Pathol; 2016 Oct; 69(10):938-41. PubMed ID: 27387984
    [TBL] [Abstract][Full Text] [Related]  

  • 97. EGFR mutation testing for squamous cell lung carcinoma.
    Liam CK; Leow HR; Pang YK
    J Thorac Oncol; 2013 Dec; 8(12):e114. PubMed ID: 24389448
    [No Abstract]   [Full Text] [Related]  

  • 98. The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.
    Bouhlel L; Hofman V; Maschi C; Ilié M; Allégra M; Marquette CH; Audigier-Valette C; Thariat J; Hofman P
    Expert Rev Anticancer Ther; 2017 Dec; 17(12):1087-1092. PubMed ID: 29069959
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Decoding the EGFR mutation-induced drug resistance in lung cancer treatment by local surface geometric properties.
    Ma L; Wang DD; Huang Y; Wong MP; Lee VH; Yan H
    Comput Biol Med; 2015 Aug; 63():293-300. PubMed ID: 25035232
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Highlights in NSCLC from the 2014 ASCO meeting.
    Socinski MA
    Clin Adv Hematol Oncol; 2014 Oct; 12(10 Suppl 18):16-9. PubMed ID: 25768033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.